CANNABINOID COMPOUND

Description

The present invention relates to a tetrahydrocannabinol (THC) type cannabinoid compound for use as a medicament. The THC type cannabinoid is an enantiomer of (-)-trans-tetrahydrocannabinol, a naturally occurring cannabinoid found in cannabis plant varieties cultivated to produce THC as the dominant cannabinoid. The particular (+)-cis-tetrahydrocannabinol enantiomer has been found to have properties that differ from those of naturally occurring (-)-trans-THC. It has been discovered that the cannabinoid (+)-cis-THC is produced in low concentrations in certain varieties of cannabis plants that have been cultivated to produce cannabidiol (CBD) as the dominant cannabinoid. Furthermore, the cannabinoid can be produced synthetically.